0001209191-20-028037.txt : 20200508
0001209191-20-028037.hdr.sgml : 20200508
20200508175404
ACCESSION NUMBER: 0001209191-20-028037
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200506
FILED AS OF DATE: 20200508
DATE AS OF CHANGE: 20200508
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Saik Andrew
CENTRAL INDEX KEY: 0001616284
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38356
FILM NUMBER: 20862032
MAIL ADDRESS:
STREET 1: 640 LEE ROAD
CITY: CHESTERBROOK
STATE: PA
ZIP: 19087
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Menlo Therapeutics Inc.
CENTRAL INDEX KEY: 0001566044
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 453757789
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 520 U.S. HIGHWAY 22, SUITE 204
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
BUSINESS PHONE: 800-775-7936
MAIL ADDRESS:
STREET 1: 520 U.S. HIGHWAY 22, SUITE 204
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
FORMER COMPANY:
FORMER CONFORMED NAME: Menlo Therapeutics, Inc.
DATE OF NAME CHANGE: 20170728
FORMER COMPANY:
FORMER CONFORMED NAME: Tigercat Pharma, Inc.
DATE OF NAME CHANGE: 20130104
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-05-06
0
0001566044
Menlo Therapeutics Inc.
MNLO
0001616284
Saik Andrew
520 U.S. HIGHWAY 22, SUITE 204
BRIDGEWATER
NJ
08807
0
1
0
0
Chief Financial Officer
Common Stock
2020-05-06
4
A
0
250000
0.00
A
300000
D
Stock Options
1.95
2020-05-06
4
A
0
250000
0.00
A
2030-05-06
Common Stock
250000
250000
D
Represents restricted stock unit awards, each of which by its terms represents a contingent right to receive one share of common stock of Menlo Therapeutics Inc.
The awards vest over four years, 25% on June 30, 2021 and 6.25% every three months thereafter, ending on June 30, 2024.
/s/ Mutya Harsch, attorney-in-fact for Andrew Saik
2020-05-08